NEWRON PHARMA N/ IT0004147952 /
11/11/2024 17:30:36 | Chg. -0.110 | Volume | Bid21:13:16 | Ask21:13:16 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
7.790CHF | -1.39% | 28,317 Turnover: 221,884.310 |
7.800Bid Size: 128 | 8.100Ask Size: 1,945 | 139.02 mill.CHF | - | - |
Assets
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | .1000 | .1000 | .1000 | .1000 | .1000 | ||||||
Intangible Assets | 9.1000 | 7 | .3000 | .3000 | 0.0000 | ||||||
Long-Term Investments | .6000 | .6000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Fixed Assets | 9.8000 | 7.7000 | .4000 | .5000 | .2000 | ||||||
Inventories | .3000 | .1000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Accounts Receivable | - | - | - | - | - | ||||||
Cash and Cash Equivalents | 18.4000 | 18.8000 | 36 | 42.9000 | 56.3000 | ||||||
Current Assets | 21.8000 | 29.4000 | 44 | 56.1000 | 72.8000 | ||||||
Total Assets | 31.6000 | 37.1000 | 44.4000 | 56.6000 | 73 |
Liabilities
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 3.7000 | 3.8000 | 6.2000 | 6.3000 | 4.7000 | ||||||
Long-term debt | 1.1000 | .7000 | .4000 | - | - | ||||||
Liabilities to Banks | 1.5000 | 1.1000 | .8000 | .4000 | 0.0000 | ||||||
Provisions | 2.9000 | 2.3000 | .1000 | .1000 | - | ||||||
Liabilities | 10.5000 | 7.8000 | 7.3000 | 6.8000 | 5.3000 | ||||||
Share Capital | 2.3000 | 2.6000 | 2.8000 | 3.2000 | 3.6000 | ||||||
Total Equity | 21.1000 | 29.3000 | 37.1000 | 49.7000 | 67.7000 | ||||||
Minority Interests | - | - | - | - | - | ||||||
Total liabilities equity | 31.6000 | 37.1000 | 44.4000 | 56.6000 | 73 |
Income Statement
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 3.5000 | 1.6000 | 2.4000 | 6.7000 | 13.4000 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | -7.8000 | -11.2000 | -24.4000 | -15.3000 | -4.3000 | ||||||
Interest Income | - | - | - | - | - | ||||||
Income Before Taxes | -7.7000 | -10.7000 | -25 | -15.2000 | -5.3000 | ||||||
Income Taxes | .6000 | .6000 | 2.2000 | 0.0000 | 0.0000 | ||||||
Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Net Income | -7.1000 | -10.1000 | -22.8000 | -15.2000 | -5.3000 |
Per Share
Cash Flow
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | -10.7000 | -10 | -12.9000 | -19.6000 | -8.4000 | ||||||
Cash Flow from Investing Activities | .2000 | -6.9000 | 2.1000 | 1.4000 | -.2000 | ||||||
Cash Flow from Financing | -.4000 | 17.2000 | 28 | 25.1000 | 22 | ||||||
Decrease / Increase in Cash | -10.8000 | .3000 | 17.3000 | 6.9000 | 13.3000 | ||||||
Employees | 23 | 23 | 23 | 23 | 23 |